Razi Vaccine and Serum Research Institute (RVSRI)
-
5mn Razi vaccine ready to be handed over to health ministry
TEHRAN, Oct. 09 (MNA) – The spokesman for the Tehran-based Razi Vaccine and Serum Research Institute has said that 5 million doses of Razi Cov Pars are ready to be handed over to the Iranian Health Ministry to help with the vaccination drive.
-
VIDEO: 3rd clinical phase of ‘COV PARS’ vaccine
TEHRAN, Sep. 05 (MNA) – The 3rd phase of a clinical trial of Razi ‘COV PARS’ vaccine began at the Razi Vaccine and Serum Research Institute in Alborz Province Sun. in the presence of Iran's Agriculture Minister Seyed Javad Sadati Nejad.
-
By: Aref Fathi Akbari
3rd clinical phase of Iranian-made Razi ‘COV PARS’ vaccine
TEHRAN, Sep. 05 (MNA) – The 3rd phase of a clinical trial of Razi ‘COV PARS’ vaccine began at the Razi Vaccine and Serum Research Institute in Alborz Province in the presence of Iran's Agriculture Minister Seyed Javad Sadati Nejad on Sunday.
-
20mn doses of Razi ‘Cov Pars’ vaccine to be produced by Dec.
TEHRAN, Sep. 05 (MNA) – Minister of Agriculture Sadatinejad said that 20 million doses of Iranian-made Razi ‘COV PARS’ vaccine will be produced by Dec.
-
VIDEO: Inhalation of first dose of Razi COV-Pars vaccine
TEHRAN, Apr. 21 (MNA) – On Wednesday, two Iranian volunteers received the first doses of the Razi COV-Pars vaccine that can be inhaled.
-
VIDEO: Razi COV-Pars human trial
TEHRAN, Feb. 28 (MNA) – The human trial of the vaccine, called Razi COV-Pars, kick-started on Sunday morning with the injection into two volunteers at Tehran's Rasoul Akram Hospital.
-
Iran to become one of vaccine manufacturing hubs in world
TEHRAN, Feb. 07 (MNA) – Saying that in the near future Iran will become one of the vaccine manufacturing hubs in the world, the Iranian Health minister announced the start of the Covid-19 vaccination on February 9.
-
Iran unveils new COVID vaccine: 'Razi Covo-Pars'
TEHRAN, Feb. 07 (MNA) – Razi Vaccine and Serum Research Institute (RVSRI) unveiled its first injectable-inhaled vaccine of Covid-19 recombinant protein, "Rzai Covo-Pars", in the presence of the minister of agriculture on Sun.
-
Iran's first recombinant COVID vaccine gets initial licence
TEHRAN, Jan. 18 (MNA) – An official with the Ministry of Health said that a clinical trial of phase one of recombinant coronavirus vaccine belonging to Razi Vaccine & Serum Research Institute was approved.
-
Razi Institute' COVID-19 vaccine to enter clinical phase soon
TEHRAN, Jan. 17 (MNA) -- Head of Pasteur Institute of Iran said that Razi Research Institute’s vaccine will enter clinical phase in coming weeks and jointly vaccine produced between Iran and Cuba will enter third phase of clinical trial in February.
-
Iran ready to test advanced generation of COVID-19 vaccine
TEHRAN, Jan. 05 (MNA) – Virology Research Director of Pasteur Institute of Iran said the the country is ready to enter human test in advanced generation of coronavirus, COVID-19, vaccine.
-
Razi institute launches SPF mice breeding system
TEHRAN, Apr. 13 (MNA) – Deputy head of Razi Vaccine and Serum Research Institute (RVSRI) announced on Monday that the body has launched breeding system of Specific-pathogen-free (SPF) mice.